Cite
HARVARD Citation
Bräutigam, J. et al. (2019). Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. Journal of molecular and cellular cardiology. pp. 97-108. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bräutigam, J. et al. (2019). Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. Journal of molecular and cellular cardiology. pp. 97-108. [Online].